Shares of Novavax Inc. NVAX slipped 2.99% to $8.43 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.20% to ...

Novavax Inc. closed 63.58% short of its 52-week high of $23.86, which the company reached on June 6th.

I have been warning about Novavax's risks since 2016, highlighting its ongoing struggles with the FDA. Novavax's Q3 2024 earnings call and 10-Q reveal a collaboration negotiated from a position of ...

Novavax (NVAX) ended the recent trading session at $8.55, demonstrating a +0.53% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.83% ...

As you can see from the chart above the percentage of shares that are sold short for Novavax has declined since its last report. This does not mean that the stock is going to rise in the near-term ...

They feared the loss of physical labor jobs, the erosion of creativity due to less manual writing or even health deterioration. Today, AI evokes similar concerns, but its broader implications make ...

Setting career goals is essential for personal and professional growth. When we set goals that are clear and measurable, we create a roadmap to achieve a rewarding career path. Goals not only give us ...

As a senior professional, taking a strategic approach to your career in 2025 will help you navigate the evolving job market and position yourself for long-term success. Here are five essential ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Novavax has a bird flu vaccine in clinical trials in addition to a COVID-19/influenza combination vaccine in late-stage trials. The Louisiana Department of Health on Monday reported the first ...